BioNTech SE (BNTX)
USD 104.08
(2.23%)
USD 104.08
(2.23%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 219.1 Million EUR | 3.25% |
| 2022 | 212.2 Million EUR | -29.62% |
| 2021 | 301.5 Million EUR | 25.53% |
| 2020 | 240.18 Million EUR | 248.58% |
| 2019 | 68.9 Million EUR | 27.09% |
| 2018 | 54.21 Million EUR | 7.68% |
| 2017 | 50.34 Million EUR | 88.79% |
| 2016 | 26.66 Million EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 254.74 Million EUR | 7.74% |
| 2024 Q1 | 236.3 Million EUR | 7.85% |
| 2023 Q3 | 201.9 Million EUR | -1.85% |
| 2023 FY | 219.1 Million EUR | 3.25% |
| 2023 Q4 | 219.1 Million EUR | 8.52% |
| 2023 Q2 | 205.7 Million EUR | -1.95% |
| 2023 Q1 | 209.8 Million EUR | -1.13% |
| 2022 Q1 | 186 Million EUR | -38.31% |
| 2022 FY | 212.2 Million EUR | -29.62% |
| 2022 Q4 | 212.2 Million EUR | -22.55% |
| 2022 Q3 | 274 Million EUR | 14.69% |
| 2022 Q2 | 238.9 Million EUR | 28.44% |
| 2021 Q2 | 256.8 Million EUR | 0.86% |
| 2021 Q1 | 254.6 Million EUR | 2684.95% |
| 2021 FY | 301.5 Million EUR | 25.53% |
| 2021 Q4 | 301.5 Million EUR | 5.16% |
| 2021 Q3 | 286.7 Million EUR | 11.64% |
| 2020 Q4 | 9.14 Million EUR | -94.79% |
| 2020 Q3 | 175.62 Million EUR | 149.86% |
| 2020 Q2 | 70.28 Million EUR | 5.47% |
| 2020 Q1 | 66.64 Million EUR | -3.28% |
| 2020 FY | 240.18 Million EUR | 248.58% |
| 2019 FY | 68.9 Million EUR | 27.09% |
| 2019 Q4 | 68.9 Million EUR | 1.61% |
| 2019 Q3 | 67.81 Million EUR | 10.57% |
| 2019 Q1 | - EUR | -100.0% |
| 2019 Q2 | 61.33 Million EUR | 0.0% |
| 2018 FY | 54.21 Million EUR | 7.68% |
| 2018 Q4 | 54.21 Million EUR | 0.0% |
| 2018 Q1 | - EUR | 0.0% |
| 2017 FY | 50.34 Million EUR | 88.79% |
| 2016 FY | 26.66 Million EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Dyadic International, Inc. | 136.92 Thousand USD | -159909.932% |
| Agenus Inc. | 350.24 Million USD | 37.444% |
| AlloVir, Inc. | 27.42 Million USD | -698.79% |
| Ardelyx, Inc. | 55.98 Million USD | -291.376% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -931.593% |
| Chimerix, Inc. | 2.14 Million USD | -10119.216% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -949.117% |
| CRISPR Therapeutics AG | 238.63 Million USD | 8.185% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -3240.448% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -111.617% |
| Fortress Biotech, Inc. | 88.59 Million USD | -147.314% |
| Fortress Biotech, Inc. | 88.59 Million USD | -147.314% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -3916.499% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -397072.12% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -138570.886% |
| IO Biotech, Inc. | 2.49 Million USD | -8685.084% |
| Structure Therapeutics Inc. | 5.45 Million USD | -3917.971% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -3453.933% |
| MiMedx Group, Inc. | 48.09 Million USD | -355.519% |
| Senti Biosciences, Inc. | 37.66 Million USD | -481.692% |
| Opthea Limited | 200.62 Million USD | -9.207% |
| Pharming Group N.V. | 171.54 Million USD | -27.722% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| PureTech Health plc | 25.51 Million USD | -758.812% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -261.676% |
| Elevation Oncology, Inc. | 30.13 Million USD | -627.013% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -475.005% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -86.957% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -252.96% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -216830.693% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -24083.223% |
| PDS Biotechnology Corporation | 23.85 Million USD | -818.596% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -13300.612% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -221.12% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -381.433% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -582.172% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | 4.403% |
| Clearside Biomedical, Inc. | 43 Million USD | -409.523% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Molecular Templates, Inc. | 12.23 Million USD | -1691.496% |
| Sorrento Therapeutics, Inc. | 134.5 Million USD | -62.895% |
| TRACON Pharmaceuticals, Inc. | 968 Thousand USD | -22534.298% |
| Vaxxinity, Inc. | 15.16 Million USD | -1344.488% |
| Viracta Therapeutics, Inc. | 25.55 Million USD | -757.333% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -3019.305% |
| Aptorum Group Limited | 3.36 Million USD | -6416.185% |
| Aridis Pharmaceuticals, Inc. | 6.13 Million USD | -3474.225% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -7528.83% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -110.305% |
| ContextLogic Inc. | 6 Million USD | -3551.667% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -116.109% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -208.696% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -272656.698% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -927.144% |
| Royalty Pharma plc | 6.13 Billion USD | 96.429% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | -4.263% |
| TG Therapeutics, Inc. | 110.79 Million USD | -97.753% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -516.224% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -792.755% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -48527.186% |
| Seer, Inc. | 28.25 Million USD | -675.328% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -75544.846% |
| NextCure, Inc. | 6.6 Million USD | -3217.184% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -68799.371% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -10234.906% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -57.592% |
| AnaptysBio, Inc. | 17.81 Million USD | -1129.932% |
| ChromaDex Corporation | 3.27 Million USD | -6585.993% |
| Precigen, Inc. | 7.09 Million USD | -2987.22% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -667.668% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -697.162% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -13154.688% |
| Acelyrin, Inc. | 1.19 Million USD | -18250.084% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -3429.317% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -2761.286% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -1416.893% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -93344.392% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -1588.502% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -38678.761% |
| AbCellera Biologics Inc. | 77.38 Million USD | -183.148% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 91.833% |
| Bicycle Therapeutics plc | 44.95 Million USD | -387.365% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -27002.852% |
| Incyte Corporation | 38.28 Million USD | -472.257% |
| Alkermes plc | 290.73 Million USD | 24.638% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -12887.552% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Onconetix, Inc. | 9.88 Million USD | -2116.317% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -2123.914% |
| Geron Corporation | 85.89 Million USD | -155.067% |
| Summit Therapeutics Inc. | 106.09 Million USD | -106.505% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -3105.56% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -1201.842% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -35124.91% |
| Innoviva, Inc. | 449.07 Million USD | 51.211% |
| Jaguar Health, Inc. | 35.86 Million USD | -510.987% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -46026.316% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -98.536% |
| Vaxcyte, Inc. | 29.22 Million USD | -649.726% |
| ADMA Biologics, Inc. | 141.41 Million USD | -54.931% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -90.239% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -102283.178% |
| Novavax, Inc. | 280.63 Million USD | 21.927% |
| eFFECTOR Therapeutics, Inc. | 19.44 Million USD | -1026.768% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -72759.927% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -12542.816% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -6059.685% |
| Precision BioSciences, Inc. | 31.26 Million USD | -600.716% |
| GT Biopharma, Inc. | 58 Thousand USD | -377658.621% |
| ImmuCell Corporation | 11.96 Million USD | -1730.516% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Mesoblast Limited | 118.92 Million USD | -84.237% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -774.93% |
| Aptose Biosciences Inc. | 1 Million USD | -21597.237% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -2531092.237% |
| Soligenix, Inc. | 3.49 Million USD | -6169.743% |
| Century Therapeutics, Inc. | 48.17 Million USD | -354.838% |
| Kura Oncology, Inc. | 17.2 Million USD | -1173.837% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -137.037% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -10090.698% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -1467.912% |
| Autolus Therapeutics plc | 52.96 Million USD | -313.654% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -3906.217% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -423.624% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | 4.503% |
| GRI Bio, Inc. | 14 Thousand USD | -1564900.0% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -1663.522% |
| IGM Biosciences, Inc. | 40.5 Million USD | -440.908% |
| INmune Bio, Inc. | 10.43 Million USD | -1999.262% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -21.974% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -3609.122% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -268141.92% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -26398.348% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -323.177% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -275.937% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -278.594% |
| Coherus BioSciences, Inc. | 480.84 Million USD | 54.434% |
| Verastem, Inc. | 41.55 Million USD | -427.228% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -3957.407% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -1826.662% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -2132.752% |
| Histogen Inc. | 4.62 Million USD | -4640.372% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 3.37 Million USD | -6384.167% |
| Organovo Holdings, Inc. | 1.39 Million USD | -15617.36% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 46 Million USD | -376.286% |
| Panbela Therapeutics, Inc. | 5.19 Million USD | -4118.329% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -1026129.508% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -159.02% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -104722.505% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -625.113% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -134882.781% |
| Apollomics, Inc. | 4.66 Million USD | -4600.708% |
| Amarin Corporation plc | 8.73 Million USD | -2407.726% |
| Turnstone Biologics Corp. | 3.21 Million USD | -6717.05% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -158.757% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -88604.453% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -124.472% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -15.35% |
| Better Therapeutics, Inc. | 14.88 Million USD | -1372.446% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -615.686% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -97.516% |
| NLS Pharmaceutics AG | 1.63 Million USD | -13310.897% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 104.77 Million USD | -109.115% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -7764.322% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -448232.31% |
| Avid Bioservices, Inc. | 207.83 Million USD | -5.421% |
| Insmed Incorporated | 1.2 Billion USD | 81.802% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.71 Million USD | -3164.789% |
| OmniAb, Inc. | 25.56 Million USD | -757.165% |
| Alector, Inc. | 38.91 Million USD | -462.979% |
| Seres Therapeutics, Inc. | 213.93 Million USD | -2.414% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 15.15 Million USD | -1346.109% |
| Revance Therapeutics, Inc. | 478.43 Million USD | 54.205% |
| Aura Biosciences, Inc. | 19.55 Million USD | -1020.315% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -246.858% |
| Immunic, Inc. | 1.33 Million USD | -16324.288% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -590.47% |
| Veracyte, Inc. | 12.63 Million USD | -1634.759% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 66.024% |
| FibroGen, Inc. | 170.45 Million USD | -28.538% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -2312.73% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -107348.838% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 96.22% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -592062.162% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -5071.112% |
| Galecto, Inc. | 249 Thousand USD | -87891.968% |
| Calithera Biosciences, Inc. | 1.66 Million USD | -13051.261% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 86.943% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -2894.397% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -3959.663% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -7764.322% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -715.074% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -386.1% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -15340.451% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -384.349% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -407.54% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -354.291% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 74.184% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -21225.718% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -1900.0% |
| NexImmune, Inc. | 68.8 Thousand USD | -318317.649% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -1543509.976% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 91.894% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -55792.572% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -3072.604% |
| Ainos, Inc. | 5.96 Million USD | -3573.982% |
| Pluri Inc. | 29.61 Million USD | -639.903% |
| Prothena Corporation plc | 11.83 Million USD | -1751.289% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -768.239% |
| Celularity Inc. | 65.41 Million USD | -234.928% |
| Rallybio Corporation | 392 Thousand USD | -55792.857% |
| Cue Biopharma, Inc. | 14.69 Million USD | -1390.983% |
| MeiraGTx Holdings plc | 89.26 Million USD | -145.452% |
| Omeros Corporation | 338.28 Million USD | 35.231% |
| Humacyte, Inc. | 58.1 Million USD | -277.069% |
| Immunocore Holdings plc | 84.03 Million USD | -160.734% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -11724.069% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -4392.516% |
| Blueprint Medicines Corporation | 774.12 Million USD | 71.697% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -4266.281% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -254.428% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -110.479% |
| Pulmatrix, Inc. | 8.75 Million USD | -2402.284% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -3067.558% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -1481.949% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -89.95% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -594.497% |
| Cytokinetics, Incorporated | 755.77 Million USD | 71.01% |
| Eloxx Pharmaceuticals, Inc. | 13.38 Million USD | -1537.029% |
| Nutriband Inc. | 241.28 Thousand USD | -90705.479% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -3907.682% |
| Vor Biopharma Inc. | 35.66 Million USD | -514.414% |
| Roivant Sciences Ltd. | 499.74 Million USD | 56.158% |
| Evogene Ltd. | 1.13 Million USD | -19153.076% |
| ProKidney Corp. | 4.41 Million USD | -4864.877% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -17771.126% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 87.407% |
| CorMedix Inc. | 667.63 Thousand USD | -32717.48% |
| BioLineRx Ltd. | 11.59 Million USD | -1790.26% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -462.95% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -205.123% |
| Atai Life Sciences N.V. | 16.47 Million USD | -1229.813% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -8839.223% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -32359.259% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -378.666% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -336976.923% |
| MediciNova, Inc. | 215.92 Thousand USD | -101369.948% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -8681.563% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -17274.713% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -17.561% |
| Biomea Fusion, Inc. | 10.29 Million USD | -2028.011% |
| PTC Therapeutics, Inc. | 415.02 Million USD | 47.208% |
| Mereo BioPharma Group plc | 5.95 Million USD | -3581.116% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -6003.064% |
| Absci Corporation | 15.95 Million USD | -1273.065% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -2291.66% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -1393.422% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -699.198% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -1687.404% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -1651.959% |
| Allakos Inc. | 41.46 Million USD | -428.397% |
| Imunon, Inc. | 1.62 Million USD | -13385.45% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -1924.767% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -144999.338% |
| BioAtla, Inc. | 2.46 Million USD | -8806.504% |
| NLS Pharmaceutics AG | 1.63 Million USD | -13310.897% |
| Bio-Path Holdings, Inc. | 113 Thousand USD | -193793.805% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -130.338% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -3850.595% |
| XOMA Corporation | 124.45 Million USD | -76.055% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -1057.239% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -407.564% |
| aTyr Pharma, Inc. | 15.09 Million USD | -1351.474% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -1867.14% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -741.301% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -940.954% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -62679.37% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -67007.105% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -13327.508% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 85.386% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -133524.449% |
| UroGen Pharma Ltd. | 100.21 Million USD | -118.632% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -19.891% |
| ZIVO Bioscience, Inc. | 346.34 Thousand USD | -63161.17% |
| Orgenesis Inc. | 22.62 Million USD | -868.569% |
| Entera Bio Ltd. | 390 Thousand USD | -56079.487% |
| GH Research PLC | 343 Thousand USD | -63777.551% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -71736.066% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -22417.986% |
| Xencor, Inc. | 83.43 Million USD | -162.603% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -126787.238% |
| Replimune Group, Inc. | 75.86 Million USD | -188.787% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -17797.022% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -2229.86% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -133524.449% |
| Portage Biotech Inc. | 47 Thousand USD | -466070.213% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -17274.713% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -8964.957% |
| OncoCyte Corporation | 2.86 Million USD | -7536.807% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -16764.016% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -145429.179% |
| Purple Biotech Ltd. | 351 Thousand USD | -62321.652% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -6835.739% |
| scPharmaceuticals Inc. | 40.26 Million USD | -444.091% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 51.19 Million USD | -327.988% |
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -154195.775% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -4088.492% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -719.433% |
| Curis, Inc. | 2.79 Million USD | -7741.804% |
| Daré Bioscience, Inc. | 5.31 Million USD | -4019.858% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -10155.335% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -1209.545% |
| BeiGene, Ltd. | 930.18 Million USD | 76.446% |
| Kiromic BioPharma, Inc. | 15.54 Million USD | -1309.683% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -149.136% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -19102.454% |
| Erasca, Inc. | 55.85 Million USD | -292.238% |
| bluebird bio, Inc. | 330.32 Million USD | 33.672% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 80.677% |
| DBV Technologies S.A. | 14.38 Million USD | -1423.538% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -8656.994% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -4617.916% |
| Travere Therapeutics, Inc. | 404.78 Million USD | 45.872% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -375.901% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -4653.743% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -8519.197% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -1062.149% |
| MacroGenics, Inc. | 33.97 Million USD | -544.962% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 20.92 Million USD | -947.123% |
| Prime Medicine, Inc. | 13.63 Million USD | -1507.13% |
| Aditxt, Inc. | 18.21 Million USD | -1102.658% |
| Adagene Inc. | 22.3 Million USD | -882.209% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -1331.745% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | 64.139% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -979.683% |
| SciSparc Ltd. | 76 Thousand USD | -288189.474% |
| Vericel Corporation | 88.14 Million USD | -148.573% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -167.14% |
| Generation Bio Co. | 97.89 Million USD | -123.814% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -66495.745% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -766.076% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | -6.403% |
| Invivyd, Inc. | 2.16 Million USD | -10020.092% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -309.793% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -6217743.024% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -3852.733% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -347677.778% |
| 2seventy bio, Inc. | 256.67 Million USD | 14.638% |
| Clene Inc. | 32.16 Million USD | -581.26% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -3804.027% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -9881.777% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -332.389% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -45427.746% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -13.41% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 30.12 Million USD | -627.279% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -1174.059% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -75.927% |
| Evaxion Biotech A/S | 10.86 Million USD | -1915.699% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -162.744% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -192.496% |
| Trevena, Inc. | 35.23 Million USD | -521.86% |
| Surrozen, Inc. | 3.37 Million USD | -6384.167% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -3272.845% |
| Cingulate Inc. | 3.13 Million USD | -6888.615% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -534290.244% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -711.782% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -43641.004% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -36234.992% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -283.008% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -47018.28% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 28.27 Million USD | -674.972% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -983.634% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -13990.032% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -17288.889% |
| Statera Biopharma, Inc. | 16.26 Million USD | -1247.384% |
| ImmunityBio, Inc. | 883.67 Million USD | 75.206% |
| Korro Bio, Inc. | 33.2 Million USD | -559.801% |
| Kineta, Inc. | 1.31 Million USD | -16536.295% |
| BioVie Inc. | 6.11 Million USD | -3485.076% |
| Codexis, Inc. | 22.36 Million USD | -879.7% |
| Celularity Inc. | 65.41 Million USD | -234.928% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -323.562% |
| Celcuity Inc. | 37.44 Million USD | -485.105% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -97581.676% |
| Cibus, Inc. | 24.62 Million USD | -789.891% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -57106.266% |
| IN8bio, Inc. | 4.89 Million USD | -4377.825% |
| Kodiak Sciences Inc. | 181.63 Million USD | -20.629% |
| Annexon, Inc. | 31.35 Million USD | -598.772% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -191.993% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -9255.252% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -5513.631% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 84.926% |
| Eyenovia, Inc. | 16.1 Million USD | -1260.214% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -96.52% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -22143.655% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -1812.368% |
| Arcellx, Inc. | 97.62 Million USD | -124.43% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -10095.44% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -726.387% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -6963.185% |
| Moolec Science SA | 2.64 Million USD | -8182.649% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -669.123% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -3370.616% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -9021.565% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -190001.862% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -547.65% |
| Humacyte, Inc. | 58.1 Million USD | -277.069% |
| 89bio, Inc. | 27.1 Million USD | -708.248% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -1549.104% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -8597.896% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -16275.187% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -106.573% |
| Notable Labs, Ltd. | 2.04 Million USD | -10593.021% |
| Liquidia Corporation | 3.5 Million USD | -6154.639% |
| Mustang Bio, Inc. | 2.49 Million USD | -8671.017% |
| Immunovant, Inc. | 138 Thousand USD | -158668.116% |
| Quantum-Si incorporated | 15.3 Million USD | -1331.745% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -2412.327% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -54675.0% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -307.947% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -268141.92% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -1909.539% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -103990.95% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -107831.034% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -960.452% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -54267.246% |
| PepGen Inc. | 20.1 Million USD | -989.833% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -38070.732% |
| United Therapeutics Corporation | 700 Million USD | 68.7% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 26.26 Million USD | -734.19% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.46 Million USD | -4809.299% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 886 Thousand USD | -24629.12% |
| XOMA Corporation | 124.45 Million USD | -76.055% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -79863.504% |
| Bionomics Limited | 239.61 Million USD | 8.563% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -10671.883% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -1550.346% |
| uniQure N.V. | 138.4 Million USD | -58.299% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -156.488% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -21130.62% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -22143.655% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -2312.73% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -12441.5% |
| Altimmune, Inc. | 671 Thousand USD | -32552.757% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | 50.771% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -1550.346% |
| Compugen Ltd. | 1.35 Million USD | -16117.617% |
| Peak Bio, Inc. | 10.72 Million USD | -1943.499% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -412.323% |
| Benitec Biopharma Inc. | 284 Thousand USD | -77047.887% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -159.121% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -999.844% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 11.77 Million USD | -1760.09% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -139.564% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -999.844% |
| Instil Bio, Inc. | 86.05 Million USD | -154.608% |
| argenx SE | 20 Million USD | -995.5% |
| Immunome, Inc. | 1.65 Million USD | -13178.788% |
| Verona Pharma plc | 51.32 Million USD | -326.854% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -2140.745% |
| Shattuck Labs, Inc. | 4.2 Million USD | -5114.184% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -60424.862% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -5140.373% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -37352.991% |
| Moolec Science SA | 2.64 Million USD | -8182.649% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -625.275% |
| Design Therapeutics, Inc. | 3.05 Million USD | -7083.607% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -83525.954% |
| NeurAxis, Inc. | 224.26 Thousand USD | -97599.099% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -1439.921% |
| Lumos Pharma, Inc. | 6.58 Million USD | -3227.259% |
| Achilles Therapeutics plc | 4.61 Million USD | -4647.562% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -2140.745% |
| 180 Life Sciences Corp. | 1.32 Million USD | -16497.617% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -1182.778% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -13990.032% |
| Nutriband Inc. | 241.28 Thousand USD | -90705.479% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -2045.305% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -26425.424% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | 41.373% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -627.931% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -5825.039% |
| Palisade Bio, Inc. | 369 Thousand USD | -59276.694% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -52695.181% |
| Beam Therapeutics Inc. | 173.17 Million USD | -26.521% |
| Neurogene Inc. | 16.25 Million USD | -1247.893% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | 28.896% |
| AEON Biopharma, Inc. | 278 Thousand USD | -78712.95% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -65302.985% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -204875.162% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -188.814% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -258.551% |
| Athira Pharma, Inc. | 1.58 Million USD | -13723.344% |
| Vaccinex, Inc. | 247 Thousand USD | -88604.453% |
| HCW Biologics Inc. | 6.45 Million USD | -3295.964% |
| XOMA Corporation | 124.45 Million USD | -76.055% |
| Nektar Therapeutics | 230.4 Million USD | 4.905% |
| Arvinas, Inc. | 3.4 Million USD | -6344.118% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -13327.508% |
| Merus N.V. | 12.16 Million USD | -1701.513% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -70.601% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -1486.072% |
| Rezolute, Inc. | 2.22 Million USD | -9733.932% |
| Clene Inc. | 32.16 Million USD | -581.26% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -125062.094% |
| BeyondSpring Inc. | 3.99 Million USD | -5384.355% |
| Synlogic, Inc. | 17.27 Million USD | -1168.307% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -16753.846% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -625900.0% |
| Peak Bio, Inc. | 10.72 Million USD | -1943.499% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -321.971% |
| Krystal Biotech, Inc. | 8.09 Million USD | -2606.944% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -23.774% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -3004.719% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -160302.36% |
| MannKind Corporation | 382.37 Million USD | 42.701% |
| Ikena Oncology, Inc. | 10.73 Million USD | -1940.417% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -53469.682% |
| Gossamer Bio, Inc. | 212.46 Million USD | -3.123% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -125819.54% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -2291.66% |
| Legend Biotech Corporation | 328.67 Million USD | 33.338% |
| Mural Oncology plc | 15 Million USD | -1359.791% |
| Biora Therapeutics, Inc. | 47.42 Million USD | -361.983% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 2.1 Million USD | -10328.367% |
| Champions Oncology, Inc. | 7.43 Million USD | -2848.856% |
| REGENXBIO Inc. | 89.29 Million USD | -145.38% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -25534.816% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -39521.543% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -3946.915% |
| Vaxart, Inc. | 26.51 Million USD | -726.356% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -1299.342% |
| Cellectis S.A. | 92.85 Million USD | -135.964% |
| Longeveron Inc. | 2.04 Million USD | -10634.934% |
| Repare Therapeutics Inc. | 3.41 Million USD | -6325.22% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 84.314% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -370.252% |
| Revolution Medicines, Inc. | 87.94 Million USD | -149.136% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -126547.399% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -5442.626% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -69016.719% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -125100.0% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 72.897% |
| Denali Therapeutics Inc. | 52.24 Million USD | -319.402% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -1420.951% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -15846.143% |
| Cingulate Inc. | 3.13 Million USD | -6888.615% |
| Passage Bio, Inc. | 26.29 Million USD | -733.27% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -3187.322% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -53600.98% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -24407.83% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -965.61% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -17288.889% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -8838.767% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -6915.69% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -26916.03% |
| OmniAb, Inc. | 25.56 Million USD | -757.165% |
| Anew Medical, Inc. | 1.6 Million USD | -13551.09% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -640.631% |
| Lipocine Inc. | 17.16 Thousand USD | -1276260.247% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -1782.626% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -532.725% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -3609.122% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -283.223% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -107831.034% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -4142.014% |
| Ocugen, Inc. | 6.94 Million USD | -3056.606% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -1450.711% |
| Q32 Bio Inc. | 1.31 Million USD | -16523.672% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -32504.167% |
| Alumis Inc. Common Stock | 32.58 Million USD | -572.498% |
| Equillium, Inc. | 824 Thousand USD | -26489.806% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -2313.261% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -72737.643% |
| Galera Therapeutics, Inc. | 152.29 Million USD | -43.862% |
| Evelo Biosciences, Inc. | 51.13 Million USD | -328.449% |
| Comera Life Sciences Holdings, Inc. | 775.04 Thousand USD | -28169.217% |
| Dominari Holdings Inc. | 3.02 Million USD | -7135.799% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -231783.751% |
| vTv Therapeutics Inc. | 529 Thousand USD | -41317.769% |
| Bio-Techne Corporation | 419.53 Million USD | 47.776% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -204.322% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -13.191% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -1197.371% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -862.569% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -3516.705% |
| Nkarta, Inc. | 88.33 Million USD | -148.022% |
| BioCardia, Inc. | 1.31 Million USD | -16561.597% |
| Iterum Therapeutics plc | 19.5 Million USD | -1023.071% |